An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 10, 2022

Primary Completion Date

September 8, 2024

Study Completion Date

September 8, 2024

Conditions

Polyarticular Juvenile Idiopathic Arthritis

Trial Locations (2)

The Children's Hospital of Chongqing Medical University /ID# 232114, Chongqing

Wuhan Children's Hospital /ID# 242274, Wuhan